Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates

24 Jan 2022

Abstract excerpt

Objectives The spread of antibiotic resistant bacteria is an important threat for human health. Acinetobacter baumannii bacteria impose such a major issue, as multidrug- to pandrug-resistant strains have been isolated, rendering some infections untreatable. In this context, carbapenem-resistant A. baumannii bacteria were ranked as top priority by both WHO and CDC. In addition, A. baumannii bacteria survive in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Berberine and alkaloids research
Share to Phytochemical compounds biological activities

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35141168
DOI: 10.3389/fcimb.2021.789672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant Acinetobacter baumannii Clinical IsolatesPMID 35141168Read ↗

Antibiotics and non-traditional antimicrobial agents for carbapenem-resistant Acinetobacter baumannii in Phase 1, 2, and 3 clinical trialsSemantic proximity Read ↗

An Update of Peptides With Therapeutic Potential Against <em>Acinetobacter baumannii </em>InfectionsSemantic proximity Read ↗

The Potential of CCA-associated Bacteria to Fight Antimicrobial-Resistant Pathogens: a Genomic SurveySemantic proximity Read ↗

Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumanniiSemantic proximity Read ↗

Evasion of Antimicrobial Activity in Acinetobacter baumannii by Target Site Modifications: An Effective Resistance MechanismSemantic proximity Read ↗

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).Semantic proximity Read ↗

Uncovering the mechanism of action of a historical antimicrobial against <i>S. aureus</i> and <i>A. baumannii</i>Semantic proximity Read ↗

Current biochemical understanding regarding the metabolism of acinetobactin, the major siderophore of the human pathogen Acinetobacter baumannii , and outlook for discovery of novel anti-infectious agents based thereonSemantic proximity Read ↗

First isolation of carbapenem-resistant Acinetobacter beijerinckii from an environmental sampleSemantic proximity Read ↗

<i>In silico</i> Identification of Novel Common Drug Targets Against Four Infectious <i>Acinetobacter</i> SpeciesSemantic proximity Read ↗

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic optionsSemantic proximity Read ↗

Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.